PD
LRMR icon

Point72 (DIFC)’s Larimar Therapeutics LRMR Stock Holding History

Point72 (DIFC)’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$32.8K Buy
+10,157
New +$38.1K ﹤0.01% 797
2025
Q2 		– Sell
-127
Closed -$274 – 1874
2025
Q1 		$274 Sell
127
-6,759
-98% -$21.4K ﹤0.01% 1606
2024
Q4 		$26.6K Buy
6,886
+3,632
+112% +$24K ﹤0.01% 1219
2024
Q3 		$21.3K Buy
+3,254
New +$26.2K ﹤0.01% 1203

Other funds holding LRMR

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Point72 (DIFC)'s LRMR Position: Q3 2025 in Review

Point72 (DIFC) opened a new position in Larimar Therapeutics (LRMR) in Q3 2025: 10,157 shares worth $32.8K. The stake represents ﹤0.01% of the portfolio and ranks #797 among its holdings. This is a return to the name: Point72 (DIFC) previously reported a position in LRMR as recently as Q1 2025.

Point72 (DIFC) first reported a position in LRMR in Q3 2024 and has held it in 4 quarters since. 136 funds tracked by Wall St. Rank hold LRMR as of Q3 2025.

  • Point72 (DIFC) held 10,157 shares of Larimar Therapeutics worth $32.8K as of Q3 2025.
  • Larimar Therapeutics was a new Point72 (DIFC) position in Q3 2025.
  • Larimar Therapeutics made up ﹤0.01% of Point72 (DIFC)'s portfolio in Q3 2025, its #797 holding.
  • Point72 (DIFC) first reported a position in Larimar Therapeutics in Q3 2024 and has held it in 4 quarters since.
  • 136 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.